Gastroenterology News

Prepregnancy bariatric surgery was linked to lower risks for gestational hypertension, large for gestational age infants and gestational diabetes but increased risks for preterm birth and small for gestational age infants, data show.

Decreases in body weight and HbA1c induced by GLP-1 receptor agonists and other diabetes drugs can reduce the risk for cardiometabolic complications for adults newly diagnosed with type 2 diabetes, researchers reported.

A simple median waiting time that did not account for censoring, death and other competing events underestimated time to organ transplantation by up to 61% compared with a competing-risk model, according to a study conducted in Switzerland.

Superabsorbent polymer beads that are often used as toys or decorations can cause bowel obstructions in young children, which may require surgery, according to research presented at the AAP National Conference & Exhibition.

Fecal microbiota-based therapies are becoming more prevalent in the management of Clostridioides difficile infection.

ORLANDO, Fla. — An analysis of the gut microbiome among individuals who survived cancer revealed a significant association between the gut-brain axis, particularly in gut microbiota, metabolism and cognitive function, according to a poster.

In 2021, Jessica Sheth Bhutada, MD, MS, and colleagues uncovered a startling 2% annual uptick in metastatic stomach cancer in young adults, despite declining rates in older adults. Three years later, they are still trying to understand why.

Cabozantinib significantly improved PFS for patients with previously treated, progressive advanced extrapancreatic or pancreatic neuroendocrine tumors, according to phase 3 study results presented at ESMO Congress.

An updated clinical practice guideline from The American Society of Colon and Rectal Surgeons underscored the need for collaborative, cross-specialty care to achieve “optimal patient outcomes” in chronic constipation.

In patients with persistent chylomicronemia, plozasiran, a small interfering RNA therapy, was associated with lower triglyceride levels and reduced risk for pancreatitis, researchers reported at the European Society of Cardiology Congress.